Elevated level of some chemokines in plasma of gastric cancer patients

Monika Baj-Krzyworzeka; Kazimierz Węglarczyk; Jarek Baran; Antoni Szczepanik; Mirosław Szura; Maciej Siedlar

doi:10.5114/ceji.2016.65133

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

4/2016
vol. 41

Send email

Copy url:

abstract:

Clinical immunology

Elevated level of some chemokines in plasma of gastric cancer patients

Monika Baj-Krzyworzeka

,

Kazimierz Węglarczyk

,

Jarek Baran

,

Antoni Szczepanik

,

Mirosław Szura

,

Maciej Siedlar

(Cent Eur J Immunol 2016; 41 (4): 358-362

DOI: https://doi.org/10.5114/ceji.2016.65133

Online publish date: 2017/01/24

View full text Get citation

PlumX metrics:

Introduction: Gastric cancer is one of the most common cancer-related causes of death. This is mainly due to the lack of good noninvasive method/biomarkers suitable for early-tumour diagnosis and planning of further therapy modalities. Chemokines play an important role in cancer progression and metastasis formation. In gastric cancer patients, clinical relevance of CXCL12 and CCL5 level has been postulated.

Aim of the study: Efforts were undertaken to examine whether expanded chemokine range may be relevant for evaluation of preoperative staging of gastric cancer patients.

Material and methods: Plasma from 66 gastric cancer patients and 11 healthy controls was obtained, and CCL2, CCL3, CCL4, CCL5, CXCL8, CXCL9, and CXCL10 levels were determined by flow cytometry FlexSet system.

Results: In gastric cancer patients’ plasma an increased level of CCL2, CCL4, CCL5, CXCL8, CXCL9, and CXCL10 was observed. In the case of CCL2, CXCL9, and CXCL10, the chemokine levels correlated with advanced (III and IV in TNM classification) disease stage. In the case of CCL4, CCL5, and CXCL8, elevated levels were observed in all cancer patients in comparison to healthy donors.

Conclusions: The accuracy of preoperative diagnosis in gastric cancer may include the monitoring of a wide range of chemokines in patients’ plasma. Increased levels of chemokines may warn that the disease is more advanced than conventional diagnostic procedures suggest.

keywords:

Elevated level of some chemokines in plasma of gastric cancer patients

Monika Baj-Krzyworzeka , Kazimierz Węglarczyk , Jarek Baran , Antoni Szczepanik , Mirosław Szura , Maciej Siedlar

gastric, cancer, chemokines

Monika Baj-Krzyworzeka

,

Kazimierz Węglarczyk

,

Jarek Baran

,

Antoni Szczepanik

,

Mirosław Szura

,

Maciej Siedlar